Αποτελέσματα Αναζήτησης
1 Μαρ 2022 · Herpes simplex virus type 2 (HSV-2) is becoming increasingly prevalent worldwide, despite the widespread use of antiviral drugs. Its ability to evade the immune system and establish a latent infection has made it difficult to develop an effective vaccine.
- Immunotherapy of HSV infections – antibody delivery - Human ...
Anti-glycoprotein g antibodies of herpes simplex virus 2...
- Immunotherapy of HSV infections – antibody delivery - Human ...
Herpes simplex virus fact sheet with key facts and information on type 1 (HSV-1) and type 2 (HSV-2): signs and symptoms, transmission, challenges, treatment, global impact and WHO response.
14 Δεκ 2023 · In a study of lab-engineered cells, Harvard Med researchers identify how the immune system neutralizes the herpesvirus. The research maps, for the first time, the maneuvers used by virus and host in the cell nucleus, a poorly understood terrain of host-pathogen interaction.
18 Αυγ 2021 · The Role of Interferons in Regulation of Adaptive Immunity During HSV-2 Infection. As we have discussed, induction of effective and appropriate innate immune responses is critical for early protection against HSV-2 infection, as well as restricting immune-mediated damage.
17 Νοε 2015 · The obstacles to creating an effective vaccine that protects someone from contracting herpes involve both the virus itself and the tissue where it typically enters the body. Most vaccines generate antibodies – the body’s natural defenses that attack invading microorganisms that can cause disease.
18 Αυγ 2021 · As large, double-stranded DNA viruses, herpesviruses rely on a multitude of means by which to counter the antiviral attack. Herein, we review the various approaches the human herpesviruses employ as countermeasures to the host innate immune response.
Anti-glycoprotein g antibodies of herpes simplex virus 2 contribute to complete protection after vaccination in mice and induce antibody-dependent cellular cytotoxicity and complement-mediated cytolysis.
